BIOMIND LABS INC. (3XI) — Financial Flexibility Index
BIOMIND LABS INC. (3XI) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of €-38.70K (operating CF €-38.70K minus capex €0.00) represents 0% of total liabilities (€1.62 Million). Check 3XI capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BIOMIND LABS INC. Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for BIOMIND LABS INC. across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does BIOMIND LABS INC. generate cash.
Annual Financial Flexibility Index for BIOMIND LABS INC. (2021–2024)
Year-by-year free cash flow to debt coverage for BIOMIND LABS INC.. Explore 3XI operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.26x | €-354.43K | €-354.43K | €1.34 Million | ▲ +48.0% |
| 2023 | -0.51x | €-765.93K | €-765.93K | €1.51 Million | ▲ +92.0% |
| 2022 | -6.39x | €-2.15 Million | €-2.15 Million | €336.72K | ▼ -3.0% |
| 2021 | -6.20x | €-2.08 Million | €-2.12 Million | €334.95K | — |